The results showed that the average tumor volume of the XPF–ERCC1 blocker with the 5-FU group was less than the 5-FU only group in both HCT116 (624 mm3; 1011 mm3) and SW620 (742 mm3; 1671 mm3). Here, ERCC1 is linked to neoplasm.